Successful adalimumab treatment of a psoriasis vulgaris patient with hemodialysis for renal failure: A case report and a review of the previous reports on biologic treatments for psoriasis patients with hemodialysis for renal failureYoshiyuki Kusakari, Setsuya Aiba, Ryoko Shimada‐Omori et al.|The Journal of Dermatology|2015Cited by 28
Body mass index, HbA1c and serum C‐reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital‐based retrospective case‐control studyH. Terui, Kenshi Yamasaki, Masayuki Asano et al.|The Journal of Dermatology|2021Cited by 4